FDA inspection
Cangene BioPharma, LLC: FDA inspection ending Mar 22, 2017
FDA inspection 1012266 · Voluntary Action Indicated (VAI) · Rockville, MD
Key facts
| Inspection ID | 1012266 |
|---|---|
| Firm | Cangene BioPharma, LLC |
| FEI number | 3008934776 |
| Address | 9920 Medical Center Dr |
| City | Rockville |
| State | MD |
| ZIP | 20850 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Mar 22, 2017 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Vaccines and Allergenic Products |
| Product type | Biologics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data